+18%

est. 2Y upside i

AI & MLSeries C

Speech-to-text and audio intelligence API platform

Rank

#3004

Sector

Voice AI / Speech Recognition

Est. Liquidity

~4Y

Data Quality

Data: Medium

AssemblyAI carries an expected equity upside of only ~18% over a 2-year horizon, which is insufficient compensation for the risks embedded in a $290M common equity stake sitting beneath $115M in liquidation preferences (39.7% preference stack — severe).

Last updated: May 5, 2026

Bull (10%)+175%

AssemblyAI dominates healthcare transcription and specialized enterprise verticals, scaling revenue from $37.4M to ~$90M by 2028 and commanding a 12x revenue multiple to reach a ~$1.08B valuation. The Universal-1 model and HIPAA-compliant Medical Mode become category-defining wedges that incumbents cannot easily replicate at equivalent accuracy.

Base (45%)+45%

Steady growth to ~$55M revenue over 2 years, supported by usage-based API adoption and healthcare expansion, drives valuation to ~$420M at 7-8x revenue. Incumbent pressure from Google and OpenAI constrains pricing power and limits multiple expansion, with a liquidity event still 3-4 years out.

Bear (45%)-45%

Commoditization of speech-to-text APIs by free or near-free offerings from OpenAI (Whisper), Google, and AWS stalls revenue near $37M and compresses the valuation multiple to 4-5x, implying a ~$160M valuation. With $115M in liquidation preferences ahead of common stock, employee equity at or below the current valuation is effectively worthless.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

40%

$115M in total funding sits ahead of common stockholders on a $290M current valuation, absorbing ~39.7% of enterprise value before employees see any proceeds in a liquidation or acquisition.

Dilution Risk

moderate

A future Series D or pre-IPO round is likely before a liquidity event, which would dilute existing employee grants by an estimated 15-25% depending on round size and structure.

Secondary Liquidity

limited

No secondary market signals are present in the data; as a Series C company with no stated IPO timeline, near-term liquidity requires a company-sponsored tender offer that has not been announced.

Other — 7 roles

View all 7 open roles at AssemblyAI →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on AssemblyAI's data — designed to show you've done your homework.

  • 1

    “How is AssemblyAI defending pricing power as OpenAI Whisper and Google Speech-to-Text push API costs toward zero — what is the moat in accuracy or features that justifies a premium?”

  • 2

    “What percentage of ARR or revenue comes from regulated verticals like healthcare, and how does the Medical Mode HIPAA BAA affect gross margin and sales cycle length?”

  • 3

    “What is the current 409A valuation used for new employee equity grants, and has the company conducted any secondary liquidity programs for early employees or explored a tender offer?”

Community

Valuation Sentiment

Our model estimates +18% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.